GenVec Company Profile (NASDAQ:GNVC)

Analyst Ratings

Consensus Ratings for GenVec (NASDAQ:GNVC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.65 (518.64% upside)

Analysts' Ratings History for GenVec (NASDAQ:GNVC)
Show:
DateFirmActionRatingPrice TargetActions
6/20/2016Rodman & RenshawReiterated RatingBuy$2.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Roth CapitalSet Price TargetBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for GenVec (NASDAQ:GNVC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/12/2016($0.09)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.08)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015Q215($0.10)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015Q115($0.06)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/24/2015Q414$0.08$0.11$3.33 million$3.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314($0.11)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214($0.15)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114$0.04($0.07)$2.00 million$2.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/28/2014Q413($0.16)($0.07)$1.52 million$0.15 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313($0.23)$2.10 million$1.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2012Q312($0.32)($0.30)$2.90 million$2.13 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GenVec (NASDAQ:GNVC)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for GenVec (NASDAQ:GNVC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GenVec (NASDAQ:GNVC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/14/2015Douglas J SwirskyCEOBuy5,000$2.00$10,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Stefan LorenDirectorBuy4,000$1.93$7,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2015Douglas E BroughInsiderBuy4,600$2.34$10,764.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Ecor1 Capital, LlcMajor ShareholderBuy24,140$2.24$54,073.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2014Ecor1 Capital, LlcMajor ShareholderBuy122,273$2.55$311,796.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GenVec (NASDAQ:GNVC)
DateHeadline
07/25/16 04:20 PMGenVec (GNVC) Says FDA Clinical Hold on CGF166 Phase 1/2 Lifted
07/22/16 07:10 AMIs $8 Price Target Attainable For GenVec, Inc. (NASDAQ:GNVC)? - Investor Newswire
07/20/16 05:40 PMGenvec Incorporated (NASDAQ:GNVC) Sellers Increased By 26.75% Their Shorts - Consumer Eagle
07/15/16 07:18 AMGenvec Incorporated (NASDAQ:GNVC) Shorted Shares Decreased By 1.99% - Press Telegraph
07/15/16 07:18 AMStrong Sell Calls For GenVec, Inc. (NASDAQ:GNVC) At 0 - Investor Newswire
07/12/16 04:32 PMWatching Unusual Volume on Shares of: GenVec, Inc. (NASDAQ:GNVC) - Engelwood Daily
07/08/16 07:07 AMIs $8 Within Reach For GenVec, Inc. (NASDAQ:GNVC)? - Investor Newswire
07/07/16 07:05 AMBroker Outlook For GenVec, Inc. (GNVC) - Fiscal Standard
07/04/16 03:55 PMCompany Stock Lower on the Week GenVec, Inc. (NASDAQ:GNVC) - Engelwood Daily
07/04/16 03:55 PMBroker Outlook For The Week Ahead GenVec, Inc. (GNVC) - Fiscal Standard
07/02/16 07:11 AMGenvec Incorporated (NASDAQ:GNVC) Shorts Decreased by 1.99% After Short Covering - Engelwood Daily
07/01/16 07:02 AMGenVec, Inc. (NASDAQ:GNVC) Expected to Reach Highs Of $8 - Investor Newswire
06/30/16 07:05 AMGenVec, Inc. (GNVC) Updated Price Targets - FTSE News
06/27/16 04:12 PMNext Weeks Broker Price Targets For GenVec, Inc. (GNVC) - Fiscal Standard
06/23/16 03:28 PMBrokers Issue Average Price Target Of 5.10 On GenVec, Inc. (GNVC) - FTSE News
06/23/16 03:28 PMStrong Sell Calls Recommendations For GenVec, Inc. (NASDAQ:GNVC) At 0 - Investor Newswire
06/22/16 04:23 PMGenVec, Inc. (GNVC) Current Analyst Ratings - Fiscal Standard
06/22/16 08:54 AMGenVec Inc (NASDAQ:GNVC) target price bumped up to $2 as issued in a report today by Rodman & Renshaw
06/21/16 04:00 PMGenVec Inc (NASDAQ:GNVC) target price bumped up to $2 as issued in a report today by Rodman & Renshaw - Breaking Finance News
06/19/16 03:56 PMGenVec, Inc. (GNVC) Analyst Price Targets For The Coming Week - Fiscal Standard
06/16/16 04:18 PMStrong Buy Calls Count For GenVec, Inc. (NASDAQ:GNVC) At 1 - Investor Newswire
06/02/16 10:22 AMGENVEC INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits -
06/02/16 04:11 AMInsiders Are Gradually Buying GenVec, Inc. (NASDAQ:GNVC) - HNN - Insiders Are Gradually Buying GenVec, Inc. (NASDAQ:GNVC)HNNAccording to the latest SEC filings, insiders at GenVec, Inc. (NASDAQ:GNVC) have increased their position in the stock by 1.89% over the past 6 months. Insiders now own 1.10% of total outstanding shares. There are both legal and illegal types of ...and more »
05/29/16 06:27 PMPerformance at a Glance on GenVec, Inc. (NASDAQ:GNVC) - HNN - Performance at a Glance on GenVec, Inc. (NASDAQ:GNVC)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how GenVec, Inc. (NASDAQ:GNVC)'s stock has performed at various points in its past. Currently, the stock ...
05/29/16 06:27 PMGenVec, Inc. (NASDAQ:GNVC) Impact Score At 0 - Investor Newswire - GenVec, Inc. (NASDAQ:GNVC) Impact Score At 0Investor NewswireAlpha One explored various online articles released on GenVec, Inc. (NASDAQ:GNVC), and it set a daily sentiment score of 0.218 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content issued ...and more »
05/23/16 11:43 AMNew Broker Ratings For GenVec, Inc. (GNVC) - FTSE News - New Broker Ratings For GenVec, Inc. (GNVC)FTSE News05/01/2015 – GenVec, Inc. had its “hold” rating reiterated by analysts at Zacks. 04/06/2015 – GenVec, Inc. had its “buy” rating reiterated by analysts at Roth Capital. They now have a USD 8 price target on the stock. The share price of GenVec, Inc ...After Recent Decline, is it Time to Sell GenVec, Inc. (NASDAQ:GNVC)Franklin Independentall 2 news articles »
05/22/16 05:59 PMAfter Last Week What Do Analysts Think Of GenVec, Inc. (GNVC) - Share Trading News - After Last Week What Do Analysts Think Of GenVec, Inc. (GNVC)Share Trading NewsThe share price of GenVec, Inc. (GNVC) was down -4.54% during the last trading session, with a day high of 0.65. 72824 shares were traded on GenVec, Inc.'s last session. The stock's 50 day moving average is 0.76 and its 200 day moving average is 1.06.and more »
05/20/16 11:39 PMRevenue Update on GenVec Inc(NASDAQ:GNVC) - Trade Calls - Revenue Update on GenVec Inc(NASDAQ:GNVC)Trade CallsGenVec Inc(NASDAQ:GNVC) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 12, 2016. Company reported revenue of $290.00K. Analysts estimated a revenue of $180.00K. Earnings per share ...
05/17/16 11:49 AMGenVec, Inc. :GNVC-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 06:16 PMGenVec, Inc. (NASDAQ:GNVC) One-Year Mean Price Target At $6.5 - Stocks Daily - GenVec, Inc. (NASDAQ:GNVC) One-Year Mean Price Target At $6.5Stocks DailySell-side analysts are confident on the future outlook of GenVec, Inc. (NASDAQ:GNVC) stock. As of 2016-05-14, the stock has an ABR of 1 rating, where number 5 denotes a Strong Sell and 1 Strong Buy. The ABR is reached on the basis of estimates of 2 ...and more »
05/12/16 07:17 AMGenVec Reports First Quarter 2016 Financial Results - [at noodls] - GAITHERSBURG, Md., May 12, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the first quarter ended March 31, 2016. For the three months ended March 31, 2016, the company ...
05/10/16 04:48 PMGENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Fi -
05/09/16 12:18 AMGenVec, Inc. (NASDAQ:GNVC) ABR Of 1 - Stocks Daily - GenVec, Inc. (NASDAQ:GNVC) ABR Of 1Stocks DailyThere are numerous brokerages operating in the market, and each one of them uses a different process to prepare the research reports on a stock. As a result, investors have to study more than one research report before taking an investment call on a stock.and more »
05/09/16 12:18 AMNext Weeks Broker Price Targets For GenVec, Inc. (GNVC) - Share Trading News - Next Weeks Broker Price Targets For GenVec, Inc. (GNVC)Share Trading NewsGenVec, Inc. has a 50 day moving average of 0.80 and a 200 day moving average of 1.14. The stock's market capitalization is 12.69M, it has a 52-week low of 0.35 and a 52-week high of 3.69. The share price of the company (GNVC) was up +6.40%, with a ...
05/05/16 08:21 AMGenVec Announces $5 Million At-The-Market Offering - [at noodls] - GAITHERSBURG, Md., May 5, 2016 /PRNewswire/ -- GenVec, Inc. (NasdaqCM: GNVC) ('GenVec' or 'the Company'), today announced that it has entered into a definitive agreement with institutional investors for ...
05/03/16 06:50 PMPortfolio Of Healthcare Movers: Gilead Sciences, Inc. (NASDAQ:GILD) , GenVec, Inc. (NASDAQ:GNVC) - Is stories - Is storiesPortfolio Of Healthcare Movers: Gilead Sciences, Inc. (NASDAQ:GILD) , GenVec, Inc. (NASDAQ:GNVC)Is storiesGilead Sciences, Inc. (NASDAQ:GILD) increased +0.90% to $89.00 while traded 13.52 million shares on 5/2/2016. The stock price negotiated for value between $86.75 to $89.45 in recent trading session. During the past 52 weeks, the stock's price witnessed ...and more »
05/03/16 06:50 PMPacira Pharmaceuticals Inc (NASDAQ:PCRX) & GenVec Inc (NASDAQ:GNVC) Active Stock's Momentum - Wall Street 24 - Pacira Pharmaceuticals Inc (NASDAQ:PCRX) & GenVec Inc (NASDAQ:GNVC) Active Stock's MomentumWall Street 24On Monday, Shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) lost -6.65% to $50.51. The share price is trading in a range of $48.51 – $55.54. The stock exchanged hands with 2.80 Million shares contrast to its average daily volume of 703,004 shares.and more »
05/02/16 07:25 PMGenVec (GNVC) Updates on CGF166 Phase 1/2; DSMB Recommends Trial Continue, Subject to Approval (NVS) - StreetInsider.com - GenVec (GNVC) Updates on CGF166 Phase 1/2; DSMB Recommends Trial Continue, Subject to Approval (NVS)StreetInsider.comGenVec, Inc. (Nasdaq: GNVC) announced that it was notified by its collaborator Novartis that the Data Safety Monitoring Board (DSMB) for the Phase 1/2 clinical trial of CGF166 in patients with severe to profound hearing loss has recommended that the ...GenVec Informed by Collaborator Novartis Phase 1/2 Clinical Trial for Hearing Loss Drug Should Continue (NASDAQ ...Sonoran Weekly Reviewall 2 news articles »
05/02/16 07:25 PMWorth Chasing Healthcare Stocks: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), GenVec Inc (NASDAQ:GNVC ... - The Point Review - The Point ReviewWorth Chasing Healthcare Stocks: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), GenVec Inc (NASDAQ:GNVC ...The Point ReviewShares of GenVec Inc (NASDAQ:GNVC) rose 32.09% to $1.03 at 11:18 AM EDT. The stock exchanged hands of 1.18 million shares recently versus average trading capacity of 108,982 shares. However recently the stock touch highest trading price of $1.40 ...and more »
05/02/16 08:29 AMGENVEC INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/02/16 06:10 AMGenVec Provides Update on Hearing Loss Clinical Program - [at noodls] - GAITHERSBURG, Md., May 2, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced today that it was notified by its collaborator Novartis that the Data Safety ...
04/28/16 07:18 PMBroker Roundup For GenVec, Inc. (GNVC) - Share Trading News - Broker Roundup For GenVec, Inc. (GNVC)Share Trading NewsThe share price of GenVec, Inc. (GNVC) was down -7.29% during the last trading session, with a day high of 1.00. 120048 shares were traded on GenVec, Inc.'s last session. The stock's 50 day moving average is 0.79 and its 200 day moving average is 1.20.
04/27/16 07:05 PMAnalyst Coverage: GenVec, Inc. (GNVC) - Risers & Fallers - Analyst Coverage: GenVec, Inc. (GNVC)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of GenVec, Inc. (GNVC). The latest broker reports which are currently outstanding on Wednesday 27th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, ...
04/20/16 07:09 PMGenVec, Inc. (NASDAQ:GNVC) Reported Basic Consolidated EPS Of $-0.3901 - Investor Newswire - GenVec, Inc. (NASDAQ:GNVC) Reported Basic Consolidated EPS Of $-0.3901Investor NewswireThe basic EPS from continuing operations as reported by GenVec, Inc. (NASDAQ:GNVC) for the period ended 2015–1-2-31 was $-0.3901. For the quarter ended 2015–1-2-31, the respective number stood at $-0.3901. For any stock there may be numerous ...
04/12/16 07:26 PMGenvec Incorporated (NASDAQ:GNVC) Sellers Increased By 99.08% Their Shorts - Business Standard Tribune - Genvec Incorporated (NASDAQ:GNVC) Sellers Increased By 99.08% Their ShortsBusiness Standard TribuneThe short interest to Genvec Incorporated's float is 2.47%. The stock increased 2.55% or $0.02 on April 12, hitting $0.8. About 31,267 shares traded hands. GenVec Inc (NASDAQ:GNVC) has declined 68.80% since September 3, 2015 and is downtrending.
04/12/16 07:26 PMNew Analyst Ratings On GenVec, Inc. (GNVC) - Risers & Fallers - New Analyst Ratings On GenVec, Inc. (GNVC)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of GenVec, Inc. (GNVC). The latest broker reports which are currently outstanding on Tuesday 12th of April state 0 analysts have a rating of “strong buy”, 2 analysts “buy”, ...
04/08/16 07:47 PMGenVec, Inc. (GNVC) Latest Broker Views - Risers & Fallers - GenVec, Inc. (GNVC) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of GenVec, Inc. (GNVC). According to the latest broker reports outstanding on Friday 8th of April, 0 analysts have a rating of “strong buy”, 2 analysts “buy”, 0 analysts ...
04/06/16 07:15 PMGenVec, Inc. (GNVC) Updated Broker Price Targets - Share Trading News - GenVec, Inc. (GNVC) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of GenVec, Inc. (GNVC). The latest reports which are currently in issue on Wednesday 6th of April state 0 analysts have a rating of “strong buy”, 2 analysts “buy”, 0 ...
03/12/16 12:04 PMGENVEC INC Financials -
03/09/16 07:01 AMGENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -

Social

About GenVec

GenVec logoGenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company's development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations. The Company's lead product candidate is CGF166. The Company's vaccine candidates include preventative vaccines against RSV and malaria, and a therapeutic vaccine for HSV. The Company is developing vaccine and anti-viral candidates for the prevention and containment of FMD outbreaks.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GNVC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.59
  • 50 Day Moving Average: $0.61
  • 200 Day Moving Average: $0.67
  • P/E Ratio: N/A
  • P/E Growth: -0.04
  • Market Cap: $13.41M
  • Beta: 2.21
  • Current Year EPS Consensus Estimate: $-0.39 EPS
  • Next Year EPS Consensus Estimate: $-0.30 EPS
Additional Links:
GenVec (NASDAQ:GNVC) Chart for Tuesday, July, 26, 2016